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Abstract
Inherited neurodegenerative disorders are debilitating diseases that occur across different
species. We have performed clinical, pathological and genetic studies to characterize a novel
canine neurodegenerative disease present in the Lagotto Romagnolo dog breed. Affected
dogs suffer from progressive cerebellar ataxia, sometimes accompanied by episodic nystag-
mus and behavioral changes. Histological examination revealed unique pathological changes,
including profound neuronal cytoplasmic vacuolization in the nervous system, as well as
spheroid formation and cytoplasmic aggregation of vacuoles in secretory epithelial tissues
and mesenchymal cells. Genetic analyses uncovered a missense change, c.1288G>A; p.
A430T, in the autophagy-relatedATG4D gene on canine chromosome 20 with a highly signifi-
cant disease association (p = 3.8 x 10-136) in a cohort of more than 2300 Lagotto Romagnolo
dogs. ATG4D encodes a poorly characterized cysteine protease belonging to themacroauto-
phagy pathway. Accordingly, our histological analyses indicated altered autophagic flux in af-
fected tissues. The knockdown of the zebrafish homologue atg4da resulted in a widespread
developmental disturbance and neurodegeneration in the central nervous system. Our study
describes a previously unknown canine neurological disease with particular pathological fea-
tures and implicates the ATG4D protein as an important autophagy mediator in neuronal ho-
meostasis. The canine phenotype serves as a model to delineate the disease-causing
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pathological mechanism(s) and ATG4D function, and can also be used to explore treatment
options. Furthermore, our results reveal a novel candidate gene for human neurodegeneration
and enable the development of a genetic test for veterinary diagnostic and breeding purposes.
Author Summary
Neurodegenerative disorders affect millions of people worldwide. We describe a novel
neurodegenerative disease in a canine model, characterized by progressive cerebellar ataxia
and cellular vacuolization. Our genetic analyses identified a single nucleotide change in
the autophagy-related ATG4D gene in affected dogs. The ATG4D gene has not been linked
to inherited diseases before. The autophagy-lysosome pathway plays an important role in
degrading and recycling different cellular components. Disturbed autophagy has been re-
ported in several different diseases but mutations in core autophagy components are rare.
Histological analyses of affected canine brain tissues revealed altered autophagic flux, and
a knockdown of the gene in the zebrafish model caused marked neurodevelopmental alter-
ations and neurodegeneration. Our findings identify a new disease-causing pathway and
implicate the ATG4D protease as an important mediator for neuronal homeostasis. Fur-
thermore, our study establishes a large animal model to investigate the role of ATG4D in
autophagy and to test possible treatment options.
Introduction
The intracellular homeostasis of neurons, especially in the cerebellar Purkinje cells, is easily dis-
turbed by dysfunction in degradative processes and accumulation of different cellular materials
[1]. The autophagy-lysosome pathway [2] and the ubiquitin-proteasome system [3] are two
major cellular degradation pathways. The autophagy (or self-eating) process is particularly im-
portant in the degradation of organelles and long-lived proteins, whereas the proteasome com-
plex targets more short-lived proteins [4, 5]. Macroautophagy (usually referred to simply as
autophagy) is an evolutionary conserved intracellular process, in which proteins and organelles
are sequestered within double-membrane autophagosomes and delivered to the lysosome for
degradation. This recycling process is orchestrated by several different autophagy related
(ATG) proteins in order to maintain proper cellular homeostasis under both basal state and
stressful conditions, such as nutrient deprivation [2]. The ubiquitin-proteasome system and
the autophagy-lysosome pathway are interlinked [4], and their dysfunction has been implicat-
ed in various detrimental neurodegenerative disorders, such as inherited ataxias, Alzheimer
and Parkinson disease, and the lysosomal storage disorders (LSDs) [6, 7].
The LSDs form a family of around 50 inherited metabolic diseases characterized by accumu-
lation of macromolecules within intracellular vacuoles of the endosomal-autophagic-lysosomal
pathways [8, 9]. LSDs can be subgrouped on the basis of the stored material, ranging from carbo-
hydrates (e.g. mucopolysaccharidoses) to different types of lipids (e.g. sphingolipidoses) and
proteins, or a combination of these [9]. Although the disease usually involves multiple organs,
central nervous system (CNS) dysfunction and neurodegeneration are present in the majority of
LSDs [8–10]. The classical causative mutations disrupt lysosomal enzymes, leading to accumula-
tion of their unprocessed substrates within lysosomes [8, 10]. However, there are LSDs that differ
from this classical example. Dysfunction of other types of proteins important for lysosomal func-
tion, such as the lysosomal membrane protein LAMP2 [11], can also cause LSD. Furthermore,
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the pathological changes in some LSDs appear to result rather from defects in intracellular mem-
brane trafficking than in processing of the lysosomal substrates, and many show signs of altered
autophagic flow [12]. In fact, the involvement of the autophagy pathways in several LSDs has
prompted a suggestion that LSDs could in part be seen as autophagy disorders [13].
Inherited neurological diseases also occur in the domestic dog (Canis lupus familiaris), and
many are caused by mutations in the same genes as corresponding human conditions [14]. In
the present work, we report a novel inherited neurodegenerative condition in the Lagotto
Romagnolo (LR) dog breed, and describe its clinical and pathological characteristics and the
likely genetic cause. The affected dogs present with progressive cerebellar ataxia, and histologi-
cal findings reveal intracellular vacuolization, altered neural autophagy and neurodegeneration.
Our results suggest that the disorder is caused by a recessive missense mutation in the ATG4D
gene, which encodes an autophagy-related proteinase [15].
Results
Clinical characterization reveals progressive ataxia with occasional
nystagmus and behavioral abnormalities
A particular neurodegenerative disease was first recognized in three LRs that presented with
progressive neurological signs. The three affected dogs comprised two full siblings and a dis-
tantly related dog. Similar clinical history, clinical examination findings and corresponding his-
tological changes in post mortem pathological examination in all three dogs indicated a shared
disease etiology.
During the course of the genetic study, we performed a detailed neurological examination in
altogether 16 affected LR dogs, and another six LRs were reported by their owners to suffer from
comparable neurological signs. The typical clinical presentation in affected dogs was progressive
ataxia (S1 Video), and many of the dog owners reported that their dogs had been a bit clumsy
even before they noticed obvious ataxia. Ten of the 22 affected dogs had episodes of abnormal eye
movements (nystagmus) and this was the first clinical sign noticed by the owners of seven affect-
ed dogs. Later in the course of the disease, the owners of seven affected LRs reported behavioral
changes, such as restlessness, depression and aggression towards people or other dogs. The age at
onset of clinical signs varied considerably between the 22 dogs; the first clinical signs were noticed
at the mean age of 23 months, ranging from 4 months to 4 years. The rate of progression of clini-
cal signs to a point where euthanasia had to be considered also varied frommonths to years.
The neurological examination in 16 affected LRs revealed a mild to severe cerebellar ataxia
in all examined dogs. The majority of dogs had normal paw positioning responses when pos-
tural reactions were tested but showed delayed onset of correction in hopping reactions. Spinal
reflexes were normal except for decreased or absent patellar reflexes in five dogs. Menace reac-
tion was decreased in eight dogs, and exaggerated in one dog. Positional nystagmus was visible
in four dogs during the neurological examination. Magnetic resonance imaging of the brain
was performed in 11 affected dogs. The principal findings included signs of mild atrophy of the
cerebellum in nine dogs and of the forebrain in six dogs. In five dogs, lateral ventricles were en-
larged. A small corpus callosum was detected in three affected dogs when compared to age
matched LRs. In two affected dogs, the brain imaging was unremarkable.
Pathological findings indicate disturbed autophagy and vesicular
trafficking
We performed pathological examination on seven LRs that were euthanized due to progressive
neurological signs. Atrophy of the cerebellum was clearly visible on macroscopic examination
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in two of the examined dogs. Histological examination revealed widespread swelling and clear
vacuolization of the neuronal cytoplasm, diffusely affecting the central and peripheral nervous
system. The cytoplasmic vacuolization varied from fine vesiculation to large confluent vacuoles
(Fig 1A). The cerebellar cortex was consistently affected (Fig 1B), showing marked progressive
Purkinje cell loss and granular cell depletion, especially in dogs with a prolonged clinical course
or more severe clinical signs (Fig 1C and 1D) The deep cerebellar nuclei, nucleus ruber, nucleus
vestibularis and the lateral and medial geniculate nuclei also showed consistent, severe changes.
The lesions were milder in the cerebral cortex, the basal ganglia and in specific nuclei, such as
the oculomotor and hypoglossal nucleus. Disturbed axonal transport was evident as numerous
morphologically diverse axonal spheroids (Fig 1E) in the cerebellar white matter, in the tha-
lamic, brainstem and cerebellar nuclei as well as in the dorsal funiculus of the spinal cord. The
spheroids were accompanied by mild to moderate astrocytosis of the cerebellar and brainstem
white matter, indicated by an increase in glial fibrillary acidic protein (GFAP)-positive cells.
In addition to the findings in neural tissue, we detected hypertrophy and vesicular vacuoli-
zation of the cytoplasm in several secretory epithelial cells, including the cells of the choroid
plexus and the subcommisural organ. Outside of the nervous system, vacuolization affected
pancreatic acinar cells (Fig 1F), the parathyroid gland, adrenal cortical cells, the prostate, the
salivary glands, the mammary gland and bronchial epithelial cells. Furthermore, vacuolization
and granular aggregates were present in cells of mesodermal origin, as seen in smooth muscle
cells, in the vascular tunica media and occasionally in endothelial cells, but also in cells with
macrophage morphology in lymphoid tissue, pulmonary alveoli and in GFAP-negative glial
cells scattered along the interface of Purkinje and granular cell layers and throughout the cere-
bellar white matter. Furthermore, fine vesicular vacuolization of the cytoplasm was seen in the
apocrine sweat glands in skin biopsies of three live dogs that suffered from corresponding clini-
cal signs. This vacuolization was comparable to that present in the secretory epithelia of the
necropsied dogs.
The content of the neuronal vacuoles did not stain in hematoxylin-eosin (HE) staining and
was periodic-acid-Schiff´s (PAS) negative, which suggests that glycogen, glycoprotein, glycolip-
id or lipofuscin did not accumulate within the vacuoles. Electron microscopy sections of Pur-
kinje cells showed single membrane bound cytoplasmic vacuoles of varying size that either
appeared empty or contained very few small membranous profiles or lucent floccular material
(Fig 1G). The vacuoles tethered and formed contact sites reminiscent of hemifusion (Fig 1G
inset). The axonal swellings contained peripherally coalescing clear vacuoles that compressed
degenerated mitochondria, occasional double-membrane-bound autophagosomes, and free
electron dense aggregated material (Fig 1H).
Genetic analyses reveal a missense variant in the ATG4D gene
At the time the genetic study was initiated, DNA samples had been obtained from only three
affected dogs. Two of these were littermates from a Finnish LR family, of which we also had
samples from two non-affected full siblings and both parents (Fig 2A). The third affected dog
was an isolated case from Switzerland. The phenotype in all three cases had been confirmed by
post mortem pathological examination. These three cases and the four controls were genotyped
on Illumina canine arrays containing more than 170 k SNPs.
We analyzed the SNP array data by performing linkage analysis and homozygosity map-
ping. Parametric linkage analysis was carried out for the Finnish LR family under a fully pene-
trant, monogenic, autosomal recessive model of inheritance. Positive LOD scores were
obtained for altogether 25 genome segments that contained 276 Mb of sequence (S1 Table).
The three available cases were then analyzed to identify extended regions of homozygosity with
ATG4DMutation in a Neurodegenerative Storage Disease
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Fig 1. Histological findings in neurons and pancreas. (A) Swelling of neurons in the vestibular nucleus
due to fine vesiculation (arrows) and clear vacuolization (arrowhead) of the cytoplasm. HE, scale bar 100 μm.
(B) Clear cytoplasmic vacuolization (arrows) in cerebellar cortical Purkinje cells. HE, scale bar 100 μm. (C)
Normal cerebellar cortex of an unaffected dog shows viable Purkinje cells (arrows) and a dense granular cell
layer. HE, scale bar 100 μm. (D) Marked neuronal loss is present the cerebellar cortex of an affected dog.
The number of neurons in the granular cell layer is reduced and only scattered Purkinje cells remain (arrow).
HE, scale bar 100 μm. (E) Axonal spheroids of varying quality were seen in the white matter (arrows) of
cerebellum and brainstem. HE, scale bar 100 μm. (F) Diffuse cytoplasmic vacuolization of the exocrine
pancreatic acinar cells. HE, scale bar 100 μm. (G) Purkinje cell with numerous single-membrane bound,
cytoplasmic vacuoles tethering to each other (arrows, inset). Electronmicrograph, scale bar 2 μm. Inset: scale
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simultaneous allele sharing. Based on the pedigree records, we hypothesized that all affected
dogs most likely were inbred to one single founder animal. Under this scenario, the affected in-
dividuals were expected to be identical by descent (IBD) for the causative mutation and flank-
ing chromosomal segments. The homozygosity mapping identified 11 genome regions that
fulfilled our homozygosity search criteria, with a total size of 38Mb (S2 Table). The linked in-
tervals from the family of six were intersected with the homozygous intervals from the three
cases. Only three chromosomal segments, on canine chromosomes 11, 13 and 20, were found
to be overlapping. These three segments had a combined size of 19 Mb, and were considered
the minimal critical interval for the subsequent analyses (Fig 2B and S3 Table).
In order to obtain a comprehensive overview of all variants in the 19 Mb critical interval, we
sequenced the whole genome of one pathologically confirmed affected LR. Nearly 210 million
2 x 100 bp paired-end reads were collected from a shotgun fragment library, corresponding to
15.5x coverage of the genome. Single nucleotide and indel variants were called with respect to
the reference genome. Across the entire genome, ~7.3 million variants were detected, of which
~2.9 million were homozygous (Table 1). Within the critical intervals, there were 31,016 vari-
ants, of which 220 were predicted to be non-synonymous. The variants in the affected LR were
filtered against the genomes of 118 dogs from various different breeds that had been sequenced
for other ongoing studies (S4 Table). We hypothesized that the causative variant should be
completely absent in the other breeds. After this filtering step, only five private homozygous
variants remained within the critical intervals (Table 2). One of these variants was intergenic
and three were intronic. The remaining fifth variant was the only non-synonymous variant
(Chr20:50,618,958C>T). It represented a missense change, c.1288G>A; p.A430T, in the
autophagy related 4D, cysteine peptidase gene (ATG4D).
The ATG4D c.1288G>A variant was then confirmed by Sanger sequencing (Fig 3A) and
genotyped in altogether 2,352 LRs. In the entire LR cohort, 25 (1%) dogs were homozygous for
the variant allele (A/A), 266 (11%) dogs were heterozygous (G/A) and 2,061 (88%) were homo-
zygous for the reference allele (G/G) (S5 Table). Out of the 25 dogs that were homozygous for
the variant, 22 were suffering or had suffered from compatible clinical signs (S6 Table). Seven
of these had been confirmed as affected through an autopsy and three through a skin biopsy.
Three dogs homozygous for the variant were classified as asymptomatic. At the time of writing
these three dogs were aged 4, 7 and 12 years (S6 Table). However, the 4-year-old dog had pre-
sented with questionable cerebellar signs when examined by a neurologist at the age of 2 years
and 11 months, and the 7-year-old dog had possible mild ataxia of hind limbs when its gait was
reviewed from video material. A skin biopsy was later obtained from the 7-year-old dog but it
did not show the sweat gland vacuolization present in other affected dogs. Finally, the gait of
the 12-year-old dog was evaluated as normal through video material. However, even when
these three dogs were placed to the control group, the association between the disease and the
variant was still highly significant (p = 3.8 x 10-136).
To corroborate the association results, the ATG4D c.1288G>A variant was screened in a co-
hort of 642 randomly selected dogs from 40 other breeds, including closely related breeds to the
LR such as the Barbet, and the Spanish and Portuguese Water Dogs (S5 Table). The variant was
not found in this sample cohort, suggesting it is not a common polymorphism, but rather has an
allele distribution that is consistent with a relatively young, breed-specific disease-causing variant.
bar 1 μm. (H) Axonal spheroid containing aggregated degenerated mitochondria, occasional double-
membrane-bound autophagosomes (arrows) and free electron dense material, compressed by a peripheral
clear vacuolar space. Electronmicrograph, scale bar 0.5 μm. Abbreviations: n, nucleus; ml, molecular layer;
pl, Purkinje cell layer; gl, granular cell layer.
doi:10.1371/journal.pgen.1005169.g001
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Fig 2. Linkage analysis and homozygosity mapping. (A) A family comprising six animals and one very distantly related case were available for the initial
mapping of the disease locus. We performed parametric linkage analysis for a recessive trait in the family and homozygosity analysis across the three cases.
(B) The analyses yielded 25 linked genome segments (orange) and 11 homozygous genome segments (red). Only three regions on chromosomes 11, 13,
and 20 showed both linkage and homozygosity and were considered the critical intervals (arrows).
doi:10.1371/journal.pgen.1005169.g002
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All 25 LRs homozygous for the ATG4D variant could be drawn into a single pedigree (S1
Fig). The 25 homozygous dogs belonged to 20 different litters. DNA samples and genotypes
were obtained from altogether 22 parents and 27 unaffected full siblings of homozygous dogs.
In two of the litters, one affected parent was homozygous for the variant but otherwise the sam-
pled parents were heterozygous and unaffected. The full siblings were either heterozygous (22
out of 27) or had a wild-type genotype (5 out of 27).
Bioinformatic analysis of the ATG4Dmissense variant
The mammalian ATG4D protein belongs to the ATG4 family of cysteine proteinases, together
with ATG4A, B and C [15]. The c.1288G>A variant is located in the last exon of the canine
ATG4D gene (Fig 3B). At the protein level, the missense variant is predicted to cause an alanine
to threonine amino acid change, p.A430T. The main functional domain of the ATG4D protein,
the C54 peptidase domain, is located at the center of the protein body. The amino-terminal re-
gion of the ATG4D protein is suggested to contain a PEST sequence, a caspase site and a cryp-
tic mitochondrial target sequence, and the carboxy-terminus holds a putative Bcl-2 homology-
3 (BH3) domain [16, 17]. The alanine at position 430 does not reside in any of the known do-
mains but is centered between the peptidase domain and the BH3 motif near the carboxy-ter-
minus (Fig 3C). The position is moderately conserved in evolution as is seen in an alignment of
41 different vertebrate species (Fig 3D). A large majority (37 out of 41) of the species has either
an alanine or valine at the position, both of which are non-polar, hydrophobic amino acids,
whereas four of the investigated species possess a serine residue. Alignment of all four ATG4
paralogs from human and dog revealed valine residues at the corresponding positions in
Table 1. Variants detected by whole genome re-sequencing of an affected Lagotto Romagnolo.
Filtering step Number of
variants
Variants in the whole genomea 2,944,010
Variants in the critical intervals on CFA 11, 13, and 20 31,016
Variants in the critical intervals that were absent from 118 other dog genomes 5
Non-synonymous variants in the whole genome 9,871
Non-synonymous variants in the critical intervals on CFA 11, 13, and 20 220
Non-synonymous variants in the critical intervals that were absent from 118 other dog
genomes
1
aThe sequences were compared to the reference genome (CanFam 3.1) from a Boxer. Only those variants
that were homozygous in the affected Lagotto Romagnolo are reported.
doi:10.1371/journal.pgen.1005169.t001
Table 2. Private sequence variants in an affected dog in the critical intervals.
Chr Position (bp)a Ref. allele Alt. allele Gene Variant (transcript) Variant (protein) Trancript reference
Chr13 5,167,594 CTGTGTGTA C Intergenicb - - -
Chr13 5,635,540 A T DPYS c.790+3201T>A (intron) XM_003639441.2
Chr20 50,618,958 C T ATG4D c.1288G>A p.A430T XM_542069.3
Chr20 50,679,224 C A PDE4A c.1548+118G>T (intron) XM_003432782.3
Chr20 53,431,352 G C EMR1 c.1366+159C>G (intron) XM_005632337.1
aPositions refer to CanFam 3, NCBI annotation release 103.
bDistances to the 5’- and 3’-ﬂanking genes (LOC102152837 and LOC102154253) are 190,888 and 266,309 bp, respectively.
doi:10.1371/journal.pgen.1005169.t002
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Fig 3. A missense variant in the ATG4D gene. (A) Chromatograms showing the c.1288G>A variant in a wild-type, carrier and an affected dog. (B) A
schematic presentation of the canine ATG4D gene. The missense variant is positioned in the last exon of the gene. (C) The domain structure of the ATG4D
protein. The p.A430T change is situated between the functional domains near the carboxy-terminus. (D) The canine ATG4D 430 alanine residue shows a
moderate degree of conservation across the animal kingdom. (E) Conservation of the 430 alanine in the ATG4 protein family in human and dog.
doi:10.1371/journal.pgen.1005169.g003
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ATG4A, ATG4B, and ATG4C (Fig 3E). We used the PredictSNP program to provide a consen-
sus pathogenicity estimate from several independent prediction algorithms on the functional
effect of the p.A430T change [18]. The alanine to threonine change was estimated to be neutral
with 85% confidence, which would suggest that the variant does not severely disrupt the pro-
tein but may still have an effect on its function.
Analysis of the ATG4D transcript
We then examined whether the ATG4D gene is expressed in the affected tissue and if the muta-
tion has an effect on mRNA splicing or mRNA expression levels. We sequenced the ATG4D
transcript using RNA samples extracted from the cerebellar cortex of two affected, two carrier
and two wild-type LRs. The obtained sequences were in accordance with the reference
(XM_542069.3), and the c.1288G>A variant was present in the transcripts of the two affected
and two carrier dogs. We did not identify splicing defects or changes in transcript levels. Both
transcript alleles were present at comparable levels in the heterozygous carrier dogs (S2 Fig).
These results suggest that the canine phenotype is caused by a dysfunction at the protein level
and not by any change on the transcript level.
Histological analyses reveal altered autophagy pathway in the affected
neurons
We next used immunohistochemistry (IHC) to examine the nature of the neuropathological
changes in more detail. For this purpose, we used antibodies produced against ATG4D, ubiqui-
tin, the autophagosome membrane marker LC3B, the lysosome membrane marker LAMP2
and the autophagic cargo marker p62, which binds ubiquinated material destined for autop-
hagy. The axonal spheroids showed strong diffuse immunoreactivity for LC3B (Fig 4A), and
the granular core was immunoreactive for ubiquitin (Fig 4B) and p62 (Fig 4C), indicating dis-
turbed autophagy in the neurites. Within the cerebellar granular cell layer and cerebellar white
matter, the ATG4D protein was detected within the finely granular swollen axons (Fig 4D).
Some vacuoles in the neuronal soma were positive for the lysosomal marker LAMP2 (Fig 4F).
The ultrastructure of these single membrane bound vacuoles was consistent with distended
secondary lysosomes or autolysosomes, containing digested material. Some vacuoles, however,
remained unstained with all antibodies used (Fig 4F). Coarse LC3B positivity was present in
the perinuclear area in several Purkinje cells, indicating induction of autophagy or blockage of
the autophagic flow in the cerebellum of affected dogs (Fig 4E). Although the cause and origin
of the neuronal vacuoles remains to be investigated in more detail, these results indicate alter-
ations in the autophagy pathway in neurons of the affected dogs.
Knockdown of zebrafish atg4da results in the CNS neurodegeneration
As the biological role of ATG4D is not well characterized, we decided to employ the zebrafish
(Danio rerio) model to get insights into its neurodevelopmental role. The zebrafish model with
its structural and functional similarities with mammalian organs and tissues provides an excel-
lent platform to study gene function during development. Due to the teleost genome duplica-
tion, the mammalian ATG4D gene has two homologs in the zebrafish, atg4da and atg4db. The
zebrafish atg4db gene sequence has greatly diverged from its mammalian homologs and codes
for a polypeptide of less than 150 amino acids. In contrast, zebrafish atg4da codes for a protein
of 485 residues with 54% identity to the 473 amino acid canine protein. We therefore consid-
ered zebrafish atg4da the functional homolog of the mammalian ATG4D protein. As a step to-
wards understanding the functional role of atg4da, we carried out an oligonucleotide-based
knockdown of the zebrafish atg4da gene by injecting a splice morpholino (atg4daSMO) into
ATG4DMutation in a Neurodegenerative Storage Disease
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1-cell staged wild-type embryos. The efficiency of the atg4daSMO was evaluated by RT-PCR,
using primers targeting the first four exons. In comparison to a single intense band detected in
standard control morpholino (stdMO) injected embryos, the atg4damorphant embryos
showed three discrete bands; a wild-type band, a smaller band that excluded exon three (84 bp)
and a larger band resulting from heteroduplex formation between the wild-type PCR product
and the abnormally spliced product (Fig 5G). This indicates that the morpholino injection pro-
duced defects in proper splicing of the atg4da transcript.
Fig 4. Immunohistochemistry indicates disturbed autophagic flow in neurons. (A) Axonal spheroids stain diffusely positive for LC3B. IHC LC3B, scale
bar 100 μm. (B,C) The granular cores of the spheroids are positive for (B) ubiquitin (arrow) and (C) p62. IHC ubiquitin and p62, scale bars 20 and 100 μm,
respectively. (D) Smooth axonal swellings in the cerebellar cortex contain ATG4D. Inset: control. IHC ATG4D, scale bar 100 μm. (E) Affected neurons show
increased perinuclear granular LC3B positivity. Inset: control. IHC LC3B, scale bar 100 μm. (F) Neuronal vacuoles are partially LAMP2 positive (arrow) and
partially negative (arrow head). Inset: control. IHC LAMP2, scale bar 20 μm.
doi:10.1371/journal.pgen.1005169.g004
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At 26 hours post fertilization, the atg4damorphants displayed severe visible malformations
in the developing CNS, in regions that correspond to the midbrain-hindbrain boundary, the
cerebellum and the hindbrain region (Fig 5C and 5D), whereas the stdMO injected embryos
appeared normal (Fig 5A and 5B). In addition, widespread neurodegeneration was present in
different regions of the atg4damorphant brain, which could be detected as widespread dark
coloration (Fig 5C and 5D). These morphological defects resulted in a small sized brain and
eye, mild hydrocephalus and occasional pericardial edema in 2-day-old morphant embryos
(Fig 5E and 5F). Although the defects in the developing CNS remained the same within the
tested morpholino dosage range, the severity of the phenotypes was dependent on morpholino
Fig 5. Phenotype of atg4damorphant zebrafish embryos. (A-F) Lateral views of control and morphant zebrafish embryos. (A,B) Control embryos appear
normal at 1 dpf. (C,D) Morphant embryos show severe abnormalities in different regions of the brain at 1 dpf. Black arrowheads denote the developing
cerebellum. Purple arrows indicate the hindbrain irregularities. (E) Control embryo at 2 dpf. (F) A morphant embryo at 2 dpf displaying hydrocephalus (yellow
arrow) and small head and eye. (G) RT-PCR assay showing the efficiency of the atg4daSMO.
doi:10.1371/journal.pgen.1005169.g005
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penetrance as some injected embryos showed stronger phenotypes, while the majority had
milder morphological defects.
The ataxia phenotype in LR dogs with progressive loss of cerebellar Purkinje cells prompted
us to examine the cerebellar region of atg4damorphants in more detail. We sought to deter-
mine whether the differentiation of the cerebellar Purkinje cells and granule cells was affected
in the morphants. Immunostaining with the Purkinje cell markers parvalbumin 7 (Pvalb7) and
zebrinII revealed partial loss of Purkinje cells in the cerebellum of atg4damorphants at 4.5
days post fertilization (dpf) (9 out of 14 morphants). In severely affected morphants, we de-
tected either total loss of Purkinje cells or a few differentiated Purkinje cells, which were located
laterally in the cerebellum (5 out of 15 morphants) (Fig 6A–6F). Immunostaining with the
granule cell marker Vglut1 antibody revealed marked loss of granule cells in morphants that
had a severe phenotype (4 out of 10 morphants). In morphants with a mild phenotype, the ex-
pression of Vglut1 was also reduced when compared to control embryos. These results suggest
Fig 6. Suppression of atg4da in zebrafish leads to loss of cerebellar neurons. Immunostaining with (A-C) anti-Pvalb7 and (D-F) anti-zebrinII antibody
show loss of cerebellar Purkinje cells in atg4damorphants. (A,D) Control embryos at 4.5 dpf. (B,E) Morphants with mild phenotype show partial loss of
cerebellar Purkinje cells. (C,F) Morphants with strong phenotype show either total loss of Purkinje cells or presence of few differentiated neurons, which are
laterally located in the cerebellum. (G-I) Labeling of cerebellar granule cells with anti-Vglut1 antibody in control and morphant embryos. (H) Mildly affected
morphants show reduced expression of Vglut1 in the cerebellum. (I) Vglut1 expression is strongly reduced in embryos showing severe phenotype. White
arrowheads indicate the region of cerebellum. Abbreviations: hb, hindbrain.
doi:10.1371/journal.pgen.1005169.g006
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that the developmental cerebellar malformation induced by the loss of atg4da function could
be caused by either a total loss or severe reduction of neurons in the cerebellum (Fig 6G–6I).
Discussion
We describe a novel neurodegenerative storage disease with a recessive missense variant in the
autophagy-related ATG4D gene. The affected dogs suffer from progressive cerebellar ataxia
with a varying age of onset and disease progression. Histological findings reveal cerebellar de-
generation and vacuolar changes in a variety of tissues, including neurons, secretory epithelia
and cells of the mesenchymal origin. The lesions in affected dogs provide evidence of altered
autophagy. Furthermore, a morpholino knockdown of the ATG4D zebrafish homologue re-
vealed a neurodegenerative phenotype in the developing fish CNS.
Our genetic studies revealed a highly significant association between the canine disease and
the ATG4D variant. The ATG4D gene encodes a C54 endopeptidase that is thought to function
in the macroautophagy pathway [15]. Four ATG4 family members (ATG4A-D) have been
identified in higher organisms [15] but their specific functional roles are poorly characterized.
The yeast possesses only a single Atg4 protein, the role of which as a processor of the ubiqui-
tin-like Atg8 protein has been extensively studied [19–21]. The yeast Atg4 cleaves Atg8 at the
carboxy-terminus to reveal an evolutionary conserved glycine residue (the so called priming
process), which allows the covalent attachment of the lipid phosphatidylethanolamine (PE) to
the cleaved Atg8 and the subsequent attachment of the lipidated Atg8 to the forming autopha-
gosomal membrane [20–22]. Later on, Atg4 functions as a deconjugating enzyme that delipi-
dates Atg8, which is then recycled from the autophagosomal membranes [20, 23, 24]. The
association of the Atg8-PE with the autophagosomal membrane is considered a critical step in
the biogenesis of autophagosomes [23–26]. Similar to the ATG4 proteins, mammals possess
several homologs of the yeast Atg8 [27]. Even though the degree of functional redundancy be-
tween the mammalian Atg4 and Atg8 homologs is not well established, differences in expres-
sion patterns [15, 28–30], functional properties [15–17, 29, 31, 32] and ATG4 substrate
specificities [16, 33, 34] have been indicated. So far, no disease causing-mutations have been re-
ported for any of the human ATG4 genes. The effects of Atg4a and Atg4d deficiency remains
to be examined in mouse models, while only mild phenotypes are seen in murine Atg4b and
Atg4c knockouts, such as mild motor incoordination in Atg4b knockout mice [32, 35, 36].
To gain a better understanding of the roles of the ATG4D protein, we studied its function in
a zebrafish model. The knockdown of the zebrafish Atg4da revealed a neurodegenerative phe-
notype with either total or partial loss of Purkinje and granule cells in the cerebellum, suggest-
ing a functional conservation of ATG4D between zebrafish and dog. Although the canine and
zebrafish proteins may possess species-specific functional differences, the severe phenotype of
the Atg4d knockdown zebrafish would be in accordance with a milder effect of the missense
mutation in dogs. A complete loss-of-function of the canine ATG4D would likely cause a more
severe phenotype than what is seen in affected LRs. Partial function of the ATG4D protein may
also explain the variable age of onset and progression in the affected dogs. Furthermore, as clin-
ical signs could not be confirmed in three dogs homozygous for the ATG4D variant, the possi-
bility of a reduced penetrance cannot be ruled out at this point.
Our results support the role of ATG4D in the autophagy-mediated neuronal homeostasis in
the CNS. We show that that the ATG4D transcript is present in the cerebellar cortex of affected
and healthy dogs. This is in accordance with publicly available RNA in situ hybridization data
from the developing and adult murine brain [37]. The mouse Atg4d is widely expressed in the
CNS, with especially strong expression in the adult cerebellum (http://www.informatics.jax.
org/assay/MGI:4945783) [37]. Outside of the CNS, ATG4D gene expression has been indicated
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in several different tissues and organs (http://www.proteinatlas.org/
ENSG00000130734-ATG4D/tissue) [15, 32]. Our results identify increased LC3B expression in
the cerebellar Purkinje cells of the affected dogs, indicating an altered autophagic pathway.
Autophagy is known to be critical for neuronal homeostasis, as implicated by the severe CNS
phenotypes in mice that lack the autophagy pathway proteins Atg5 and Atg7 [38, 39]. The neu-
ronal Atg5 and Atg7 knockouts present with behavioral deficits and progressive motor dys-
function, such as ataxia [38, 39]. At the histological level, neurodegeneration is present and
intracytoplasmic ubiquitin-positive protein inclusions accumulate in neurons [38, 39]. Nota-
bly, the neuronal Atg5 knockout mouse show degenerative changes especially in the cerebellar
Purkinje cells [38] similar to our affected dogs. Furthermore, a recent study reported corre-
sponding histological findings in dogs with a juvenile-onset progressive cerebellar ataxia,
caused by a recessive mutation in the autophagy-linked RAB24 gene [40]. Interestingly, while
the CNS changes in the affected LRs share several features with the other autophagy-impaired
models, they differ by having a unique intracellular vacuolization. In addition to the neuronal
findings, marked vacuolization of epithelial cells was present in several secretory organs in af-
fected LRs, for instance in the pancreas and salivary glands. However, these changes did not ap-
pear to translate into clinical signs, such as pancreatic insufficiency. The role of autophagy
proteins in extraneuronal tissue and in secretion pathways is an area of increasing interest [41],
and the affected LRs provide an exciting model to further investigate the role of ATG4D in
extraneuronal autophagy.
The vacuolar change in the affected dogs resembled those seen in LSDs, however, we failed
to identify any specific storage material, such as glycogen, ganglioside or other glycolipids [8].
The neuronal vacuoles and the vacuoles found in phagocytic cells stained partially positive for
lysosomal membrane antigens, indicating altered lysosomal homeostasis. Since the autophagy
pathway and lysosomal degradation are tightly linked and have common regulatory mecha-
nisms, it is not surprising that disturbed autophagic flow can affect lysosomal homeostasis. Cu-
mulating evidence shows that some storage disorders considered as primary LSDs, could be
caused at least in part by disturbed autophagy [13]. As the autophagosome matures and fuses
with the lysosome to form the autolysosome, autophagy-related markers such as LC3B are de-
graded and lysosomal markers become the main membrane protein despite the autophagic ori-
gin of the vesicle [42]. Our findings of LC3B negative, partially LAMP2 positive vesicles that
fuse into larger vesicles may indicate a disturbed end-phase of the autophagic degradation.
In conclusion, we have characterized a novel neurodegenerative disorder with unique histo-
logical changes that are linked to impaired autophagy. We identify a mutation in an autop-
hagy-related protease gene, ATG4D, which represents a novel candidate gene for
neurodegeneration. Our study establishes a novel canine model to investigate ATG4D-mediat-
ed functions in autophagy and to evaluate possible treatment options. Meanwhile, veterinary
diagnostics and breeding programs benefit from a genetic test.
Materials and Methods
Ethics statement
All dogs used in this study were privately owned pets that were examined with the consent of
their owners. The clinical and genetic experiments performed on dogs were approved by the
“Cantonal Committee For Animal Experiments” (Canton of Bern; permit 23/10) and by the
“Animal Ethics Committee at the State Provincial Office of Southern Finland” (permit: ESAVI/
6054/04.10.03/2012). All zebrafish experiments were performed in accordance to the guidelines
approved by “Stockholm North Experimental Animal committee” (Dnr N29-12).
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Animals and pedigrees
The study cohort comprised altogether 2,352 LRs and 642 dogs from 40 other breeds (S5
Table). Samples were obtained from seven LRs that were confirmed as affected by pathological
examination, and from 15 LRs with corresponding clinical signs. The remaining LR samples
included several relatives of affected dogs, such as parents and siblings but also unaffected dogs
from the general LR population.
The disease pedigree was drawn using the GenoPro genealogy software (http://www.
genopro.com/). The pedigree information was obtained from the Finnish Kennel Club’s pedi-
gree registry KoiraNet (http://jalostus.kennelliitto.fi/), the Lagotto Pedigree database (http://
lagotto.hu/database.htm) and from individual dog owners and breeders.
Clinical examinations
Detailed clinical examination was performed on 16 of the affected dogs. Clinical examinations
included general clinical and neurological examination. For the rest of the affected dogs de-
tailed history of the dogs and their clinical signs were received by phone or email interview of
the dog owners.
Necropsy and histological examinations
Seven affected dogs underwent postmortem examination after euthanasia and skin biopsies
from four live dogs were available for review. Tissue samples of internal organs, skin, central
and peripheral nervous system taken during necropsy were formalin fixed and paraffin em-
bedded for histology along with the skin biopsies. Tissue sections and skin biopsies were
stained with HE, PAS and treated with diastase for glycogen digestion. Electron microscopy
samples of the cerebellar cortex of one dog were fixed in 2.5% buffered glutaraldehyde,
washed and contrast stained with 1% osmium tetroxide and 8% uranyl acetate in 0.69% ma-
leic acid and embedded in epoxy resin. Ultrathin sections were mounted on copper grids,
stained with Reynolds lead citrate stain and viewed in Phillips EM2085 at 80 kV. Tissue sam-
ples from four affected dogs were included in the immunohistochemical stainings. Antigens
were retrieved with 0.01M citrate buffer at pH 6 and heat for 20 minutes at 99°C. The sections
were stained according to the UltraVision Detection System HRP/DAB kit (Thermo Fisher
Scientific Inc.) using primary antibodies against LC3B (ab48394, Abcam), p62/SQSTM1
(P0067, Sigma-Aldrich), ubiquitin (ab7780, Abcam), LAMP2 (LS-B3144, LifeSpan Biosci-
ences Inc.) ATG4D (SAB1301447, Sigma-Aldrich), and GFAP (MCA1909, Serotec, Bio-Rad
Laboratories Inc.). Tissue samples from an unaffected (homozygous wild-type for the
ATG4D variant) 5 year-old male LR, euthanized due to heart failure, was used as control for
the immunohistochemical stainings.
DNA samples
The majority of samples were collected as whole blood, and a small proportion as buccal swabs
or tissue samples. The genomic DNA was isolated from EDTA-blood using the Nucleon Bacc2
kit (GE Healthcare) or a semi-automated Chemagen extraction robot (PerkinElmer Chemagen
Technologie GmbH). Tissue samples were processed by using the Chemagen robot, and buccal
swabs by using the QiaAmp DNAMini Kit (Qiagen). The concentration of DNA samples was
measured by using a NanoDrop-1000 UV/Vis Spectrophotometer (Thermo Fisher Scientific
Inc.). DNA samples were stored at -20°C.
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Linkage analysis and homozygosity mapping
Genotyping of three affected and four unaffected dogs was performed at the GeneSeek facility
(Neogen Corporation) using Illumina’s CanineHD BeadChips containing 173,662 validated
SNPs. Genotypes were stored in a BC/Gene database version 3.5 (BC/Platforms). Linkage anal-
ysis was performed using SNP chip genotypes of altogether six dogs from a single nuclear fami-
ly. The family comprised the non-affected parents, two affected and two healthy siblings. The
Merlin software [43] was used to perform parametric linkage analysis under a fully recessive in-
heritance model. The PLINK v1.07 software [44] was used to search for extended intervals of
homozygosity in the three genotyped cases as described previously [45]. The final critical inter-
vals were defined by visual inspection of all SNP chip genotypes of the three cases on canine
chromosomes 11, 13, and 20 in an Excel-file.
Gene analysis
We used the dog CanFam 3.1 assembly for all analyses. All numbering within the canine
ATG4D gene correspond to the accessions XM_542069.3 (mRNA) and XP_542069.1 (protein).
Whole genome sequencing of an affected dog
We prepared a fragment library with a 300 bp insert size and collected 210,168,963 Illumina
HiSeq2500 paired-end reads (2 x 100 bp) corresponding to roughly 15.5x coverage. The reads
were mapped to the dog reference genome using the Burrows-Wheeler Aligner (BWA) version
0.5.9-r16 [46] with default settings. This resulted in altogether 380,485,021 unique mapping
reads. The Picard tools (http://sourceforge.net/projects/picard/) were used to sort the mapped
reads by the sequence coordinates and to label the PCR duplicates. The Genome Analysis Tool
Kit (GATK version v2.3–6) [47] was used to perform local realignment and to produce a
cleaned BAM file. Variant calls were then made by using the unified genotyper module of
GATK. Variant data was obtained in variant call format (version 4.0) as raw calls for all sam-
ples and sites flagged using the variant filtration module of GATK. Variant calls that failed to
pass the following filters were labeled accordingly in the call set: (i) Hard to Validate MQ0 4
& ((MQ0 / (1.0  DP))> 0.1); (ii) strand bias (low Quality scores) QUAL< 30.0 || (Quality by
depth) QD< 5.0 || (homopolymer runs) HRun> 5 || (strand bias) SB> 0.00; (iii) SNP cluster
window size 10. The snpEFF software [48] together with the CanFam 3.1 annotation was used
to predict the functional effects of detected variants. We considered the following snpEFF cate-
gories of variants as non-synonymous: non_synonymous_coding, codon_deletion, codon_in-
sertion, codon_change_plus_codon_deletion, codon_change_plus_codon_insertion,
frame_shift, exon_deleted, start_gained, start_lost, stop_gained, stop_lost, splice_site_accep-
tor, splice_site_donor. The critical intervals on chromosomes 11, 13, and 20 contained
18,984,944 bp and 103,507 coding nucleotides, respectively. In our re-sequencing data, we
had 4x coverage on 18,557,536 bp of the critical interval (97.7%) and on 98,578 (95.2%) of
the coding bases.
Sanger sequencing and TaqMan genotyping
Sanger sequencing was used to confirm the presence of the ATG4D candidate variant identified
in the whole genome scan. Both Sanger sequencing and TaqMan genotyping were then used to
genotype the variant in our full LR cohort and in dogs from 40 other breeds. Primers used in
Sanger sequencing were designed by using the Primer3 program (http://frodo.wi.mit.edu/
primer3/). PCR products were amplified using AmpliTaq Gold 360 Mastermix (Applied Bio-
systems, Life Technologies) or Biotools’ DNA Polymerase. The sequencing reactions were then
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performed on an ABI 3730 capillary sequencer (Applied Biosystems, Life Technologies), after
treatment with exonuclease I and shrimp alkaline phosphatase. The Sanger sequence data were
analyzed using Sequencher 5.1 (GeneCodes) or Variant Reporter v1.0 (Applied Biosystems,
Life Technologies). The TaqMan genotyping reactions were performed using Applied Biosys-
tems’ TaqMan chemistry and 7500 Fast Real-Time PCR instrumentation by following the
manufacturer’s instructions. Primer and probe sequences used in Sanger sequencing and Taq-
man genotyping are listed in S7 Table.
Tissue samples and mRNA experiments
Fresh tissue samples were collected in RNAlater solution (Ambion, Life Technologies) from
two affected LRs and from four unaffected LRs that were euthanized on their owners’ request,
and donated for the research. Samples were harvested immediately after euthanasia and stored
in -80°C until further use. The affected dogs were 2-year-old male littermates euthanized due
to progressive clinical signs. One control dog was an 11-month-old male LR that had suffered
from seizures of unknown etiology. Another control dog was a 10-year old female LR that was
euthanized for progressive cognitive decline. Two control dogs, a 9-year old female and a
10-year old female, were both euthanized because of a severe hip dysplasia.
Total RNA was extracted from cerebellar tissue samples by using the RNeasy Mini Kit (Qia-
gen), and sample concentrations were measured by using a ND-1000 UV/Vis Spectrophotome-
ter (Thermo Fisher Scientific Inc.). The High Capacity RNA-to-cDNA Kit (Applied
Biosystems, Life Technologies) was then used to reverse-transcribe equal amounts of total
RNA into cDNA. The canine ATG4D transcript was amplified and sequenced by using six
primers pairs (S7 Table) that were designed to span over exon-intron boundaries in order to
control for genomic DNA contamination. The PCR amplification and sequence analysis was
carried out as described in methods for Sanger sequencing. In addition, the entire ~1500 bp
ATG4D transcript was amplified from an affected and wild-type dog using the Phusion Hot
Start II High-Fidelity DNA polymerase (Thermo Fisher Scientific Inc.). The PCR products
were visualized on a 2% agarose gel.
Sequence alignment and pathogenicity prediction
Amultiple sequence alignment of the ATG4D protein was constructed by using the Clustal
Omega tool (http://www.ebi.ac.uk/Tools/msa/clustalo/). The aligned protein sequences were
derived from the Entrez Protein database (http://www.ncbi.nlm.nih.gov/protein), with the ex-
ception of the zebrafish sequence, which was obtained from the Ensembl database (http://
www.ensembl.org/). The aligned species were selected based on availability of sequences for
the ATG4D protein at the time of writing. The possible pathogenicity of the identified amino
acid change was examined by running the PredictSNP 1.0 program, which calculates a consen-
sus value using several separate prediction programs [18].
Zebrafish maintenance and morpholino injection
Embryos from wild-type AB strain were obtained by natural spawning and raised in Petri
dishes at 28.5°C in E3 medium (5 mMNaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mMMgSO4).
Embryos were treated with phenylthiourea to inhibit pigmentation, and collected at different
developmental stages.
The splice-morpholino, atg4daSMO, binding to intron1 and exon2 of atg4da pre-mRNA,
and a stdMO were purchased from Gene Tools (S7 Table). The morpholinos were dissolved in
1x Danieu’s solution and approximately 2–3 ng/embryo were injected into 1-cell stage embry-
os. The specificity of the splice morpholino was evaluated by RT-PCR using primers listed in
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S7 Table. The PCR products were visualized on 3% agarose gel and processed for sequencing
using the GenElute Gel Extraction Kit (Sigma-Aldrich). The used zebrafish atg4da reference se-
quences were ENSDART00000152289 (mRNA) and ENSDARP00000126975 (protein).
Immunostaining of zebrafish embryos
Whole-mount immunostaining on control and morphants embryos were performed using pri-
mary antibodies anti-Pvalb7 (1:1000; mouse ascites), anti-zebrin II (1:200; hybridoma superna-
tant) and anti-Vglut1 (1:1000; purified antibody) as described previously [49]. Goat anti-
mouse Alexa 488 (Molecular Probes, Life Technologies) was used as the secondary antibody.
All images were obtained using Andor spinning disk confocal microscope at
10x magnification.
Supporting Information
S1 Fig. Disease pedigree established around affected dogs. A pedigree established around the
Lagotto Romagnolo dogs homozygous for the ATG4D variant. The numbering of affected dogs
corresponds with the numbering in S6 Table. The genotypes of sampled dogs are denoted in
the pedigree. Within the affected litters, the health status of those siblings that were not sam-
pled is not known. The dogs used in genome-wide analyses are circled and the dog used for
whole genome sequencing is marked with an arrowhead.
(TIF)
S2 Fig. Analysis of the ATG4D transcript in cerebellar tissue. (A) The ATG4D transcript was
amplified using cDNA obtained from cerebellar cortical tissue samples of two affected, two car-
rier, and two wild-type dogs. Equal amounts of cDNA were used in each reaction. The band
sizes and rough expression levels do not differ between affected and healthy dogs. (B) The full-
length ATG4D transcript was amplified from cerebellar cortex of an affected and a wild-type
dog, showing uniform transcript sizes and levels. (C) Chromatograms obtained from the se-
quencing of the ATG4D transcript. In the heterozygous carrier dog, both alleles are represented
at roughly equal amounts. Abbreviations: wt, wild-type; het, heterozygous; mut, mutant; G, ge-
nomic DNA.
(TIF)
S1 Table. Linkage analysis.
(XLSX)
S2 Table. Homozygosity mapping.
(XLSX)
S3 Table. Combined linkage and homozygosity results.
(XLSX)
S4 Table. Dog genomes.
(XLSX)
S5 Table. Sample cohort.
(XLSX)
S6 Table. Lagotto Romagnolo dogs homozygous for the ATG4D variant.
(XLSX)
S7 Table. Primer and probe sequences.
(XLSX)
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S1 Video. Ataxia in an affected Lagotto Romagnolo dog. Video shows progressive ataxia in
an affected female Lagotto Romagnolo dog. The progression of clinical signs was recorded at
the age of 7 and 18 months. The age of disease onset in the dog was 4 months and the age at eu-
thanasia 20 months.
(MOV)
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